senate Bill S2327

2009-2010 Legislative Session

Adds G6PD deficiency to the list of testing for neonatal screenings

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Committee


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

do you support this bill?

Actions

view actions (2)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Jan 06, 2010 referred to health
Feb 18, 2009 referred to health

S2327 - Bill Details

See Assembly Version of this Bill:
A6559
Current Committee:
Senate Health
Law Section:
Public Health Law

S2327 - Bill Texts

view summary

view sponsor memo
BILL NUMBER: S2327

TITLE OF BILL :

An act to amend the public health law, in relation to neonatal testing
for glucose-6-phosphate dehydrogenase (G6PD deficiency)


PURPOSE :

To provide life saving information for parents of newborn children.

SUMMARY OF PROVISIONS :

This bill would amend subdivision (a) of the Public Health Law,

ยง2500-a to add glucose-6-phosphate dehydrogenase (G6PD) deficiency to
the list of conditions for which newborn infants must be tested by
hospitals or other institutions caring for infants less than 28 days
of age.

JUSTIFICATION :

G6PD deficiency can be a life threatening condition if not carefully
managed. This common human enzyme deficiency afflicts an estimated 400
million people worldwide. The lack of this enzyme can cause anemia and
other adverse symptoms. The severity of the pathologies associated
with this deficiency has prompted a great deal of research and new
treatment techniques are being developed. Early detection of G6PD
deficiency would promote early intervention to avoid potentially
serious risks through educational and social programs including a
regimen of special diet.

LEGISLATIVE HISTORY :

S.1145/A.6568 of 2007-08 (3rd Reading 2008); S.1214/A.2358 in 2005-06
(Reported to Senate Rules 2006); S.6551/A.9905 in 2004 (Reported to
Senate Rules Committee).

FISCAL IMPLICATIONS :

Undetermined. However, such cost should be minimal in comparison to
the costs associated with medical care necessary to treat those in
whom the disease has caused pathologies because they have been unaware
of this enzyme deficiency.

EFFECTIVE DATE :
180th day following enactment; provided that the promulgation of rules
or regulations needed for implementation could be enacted prior to
such date.
view full text
The Bill text is not available.

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.